ARCHIVES

GAO Criticize NCI Contract Practices In Report On Cancer Control

This article is from The Cancer Letter archive.

Vol. 06 No. 30 | July 25, 1980

Download PDF Visit The Full Archive

Related Articles

Protocols Approved During The Month of September 2001

October 26, 2001

Senate To NCI: Return To Old Guidelines, Stop “Mixed Messages” On Mammography

February 14, 1997

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

FDA Approves Gleevec In 73 Days, A Speed Record.

May 18, 2001

Cancer Groups Fear Clinical Trials Coverage Will Not Be Implemented Across Exchanges

July 3, 2013

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

March 25, 2011